Is Evolent Health, Inc. (EVH) a Buy, Sell, or Hold?
Evolent Health, Inc.
NYSE:EVH
$5.87 USD
-$0.32 (-5.17%)
- Volume
- 2.96M
- Average Volume
- 2.55M
- Market Capitalization
- $660.26M
- P/E Ratio
- -1.25
- Dividend Yield
- 0.00%
- Price Target
- $6.50
- Year High
- $11.81
- Year Low
- $2.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $-0.01
- Current Ratio
- $1.32
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Seth Barrie Blackley |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Current Symbol | EVH |
| CUSIP | 30050B101 |
| CIK | 0001628908 |
| Web | https://www.evolent.com |
| Phone | 571 389 6000 |
| Currency | USD |
| Employees | 4200 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 2.49 |
| Payout Ratio | -0.01 |
| Current Ratio | 1.32 |
| Quick Ratio | 1.32 |
| Cash Ratio | 0.44 |
Sales & Book Value
| Annual Sales | $1.88B |
| Price / Sales | 0.35 |
| Cash Flow | 0.01 |
| Price / Cash Flow | 473.31 |
| Price / Book | 1.66 |
Price Target and Rating
| Average Stock Price Forecast | $6.50 |
| High Stock Price Forecast | $10.00 |
| Low Stock Price Forecast | $3.50 |
| Forecast Upside/Downside | -9.69% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 29 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-5.07 |
| Trailing P/E Ratio | -1.25 |
| PEG Ratio | 0.01 |
| P/E Growth | 0.01 |
| Net Income | $-534.51M |
| Net Margin | -26.29% |
| Pretax Margin | -26.32% |
| Return on Equity | -77.89% |
| Return on Assets | -26.43% |
Financials Score
| AltmanZ Score | -0.41 |
| Piotroski Score | 4.00 |
| Working Capital | 120.78M |
| Total Assets | 1.88B |
| Ebit | -433.26M |
| Market Cap | 652.95M |
| Total Liabilities | 1.48B |
Poll Results
About Evolent Health, Inc. (NYSE:EVH) Stock
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intel ... ligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
2026-07-08 16:30:00
WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open, with a conference call to follow at 8 a.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.
Should You Buy Evolent Health (EVH) After Golden Cross?
2026-07-03 10:56:10
Evolent Health, Inc (EVH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EVH's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
2026-06-29 11:56:15
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Agentic AI Powers U.S. Healthcare Stocks
2026-05-17 20:19:15
Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating agentic AI as the cheapest unit of labor on the market.
Evolent Health Q1 Earnings Call Highlights
2026-05-10 05:13:41
Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early progress on major client launches and continued investment in automation.
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
2026-05-08 17:31:15
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
2026-05-07 10:31:28
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 09:56:08
Evolent Health (EVH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.06 per share a year ago.
Frequently Asked Questions
-
What is the current Evolent Health, Inc. (EVH) stock price?
-
Evolent Health, Inc.(NYSE:EVH) stock price is $5.87 in the last trading session. During the trading session, EVH stock reached the peak price of $11.81 while $2.095 was the lowest point it dropped to. The percentage change in EVH stock occurred in the recent session was --5.17% while the dollar amount for the price change in EVH stock was -$-0.32.
-
EVH's industry and sector of operation?
-
The NYSE listed EVH is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of EVH?
-
Jessica White | Chief Information Officer
Katie DiPerna Cook | Chief Operating Officer
John Tam | Chief Growth Officer
John Paul Johnson | Chief Strategy Officer
Jonathan David Weinberg | Chief Legal Officer, General Counsel & Secretary -
How many employees does EVH have?
-
Number of EVH employees currently stands at 4200. EVH operates from 800 North Glebe Road, Arlington, VA 22203, US.
-
Link for EVH official website?
-
Official Website of EVH is: https://www.evolent.com
-
How do I contact EVH?
-
EVH could be contacted at phone #571 389 6000 and can also be accessed through its website. EVH operates from 800 North Glebe Road, Arlington, VA 22203, US.
-
How many shares of EVH are traded daily?
-
The average number of EVH shares traded daily for last 3 months was 2.55M.
-
What is the market cap of EVH currently?
-
The market value of EVH currently stands at $660.26M with its latest stock price at $5.87